Cargando…
Promyelinating drugs promote functional recovery in an autism spectrum disorder mouse model of Pitt–Hopkins syndrome
Pitt–Hopkins syndrome is an autism spectrum disorder caused by autosomal dominant mutations in the human transcription factor 4 gene (TCF4). One pathobiological process caused by murine Tcf4 mutation is a cell autonomous reduction in oligodendrocytes and myelination. In this study, we show that the...
Autores principales: | Bohlen, Joseph F, Cleary, Colin M, Das, Debamitra, Sripathy, Srinidhi Rao, Sadowski, Norah, Shim, Gina, Kenney, Rakaia F, Buchler, Ingrid P, Banerji, Tapasree, Scanlan, Thomas S, Mulkey, Daniel K, Maher, Brady J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10393406/ https://www.ncbi.nlm.nih.gov/pubmed/37068912 http://dx.doi.org/10.1093/brain/awad057 |
Ejemplares similares
-
Evaluation of Na(v)1.8 as a therapeutic target for Pitt Hopkins Syndrome
por: Martinowich, Keri, et al.
Publicado: (2022) -
Disordered breathing in a Pitt-Hopkins syndrome model involves Phox2b-expressing parafacial neurons and aberrant Nav1.8 expression
por: Cleary, C. M., et al.
Publicado: (2021) -
A myelin-related transcriptomic profile is shared between Pitt Hopkins syndrome models and human autism spectrum disorder
por: Phan, BaDoi N., et al.
Publicado: (2020) -
Generation of 10 patient-specific induced pluripotent stem cells (iPSCs) to model Pitt-Hopkins Syndrome
por: Sripathy, S.R., et al.
Publicado: (2020) -
Introducing Pitt-Hopkins syndrome-associated mutations of TCF4 to Drosophila daughterless
por: Tamberg, Laura, et al.
Publicado: (2015)